Top Overvalued Medical - Pharmaceuticals industry Stocks 2026

Atai Life Sciences (ATAI) has the largest fair value gap in the Medical - Pharmaceuticals industry at 85.7% above the modeled estimate, followed by Insmed (INSM) at 62.6% and Cullinan Therapeutics, (CGEM) at 11.5%.

Updated todayBased on intrinsic value modelsIndustry: Medical - Pharmaceuticals

Page snapshot: 23 Sept 2026, 9:24 am

View full analysis in the screener → · All overvalued →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Compare price vs fair value See intrinsic value →

Medical - Pharmaceuticals Industry Valuation Insights (Updated Today)

The Medical - Pharmaceuticals industry currently shows an average fair value gap of 53.3% on this snapshot.
Top name Atai Life Sciences N.V. (ATAI) trades at roughly a 85.7% gap versus modeled intrinsic value—rankings move with prices and inputs.
This industry's average fair value gap is below our broad benchmark (~94.6%).

Overvalued Medical - Pharmaceuticals Stocks by Market Cap

Large cap (top 5)

1.Insmed Incorporated · INSM62.6%$26.19B

Mid cap (top 5)

1.Atai Life Sciences N.V. · ATAI85.7%$2.72B

Small cap (top 5)

1.Cullinan Therapeutics, Inc. · CGEM11.5%$1.33B

What Are Overvalued Medical - Pharmaceuticals Stocks?

Overvalued medical - pharmaceuticals stocks are names where price sits above modeled fair (intrinsic) value—shown as a fair value gap versus the current quote.

This is not a sell list. Validate each symbol on its company page before you act.

How We Identify Overvalued Medical - Pharmaceuticals Stocks

We pull an industry-filtered overvalued snapshot (price, fair value gap, cap, sector, country) and rank by that gap. You can sort and search in the table above.

Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.

FAQs

Answers about overvalued medical - pharmaceuticals names, intrinsic value, and how often this list refreshes.

What are overvalued medical - pharmaceuticals stocks?

They are Medical - Pharmaceuticals names trading above modeled intrinsic value—shown here as a fair value gap versus price. Models vary; use this as a screen, not advice.

How do you find overvalued medical - pharmaceuticals stocks?

We load overvalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.

Why are medical - pharmaceuticals stocks overvalued?

Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.

Is this medical - pharmaceuticals list a recommendation to buy or sell?

No. Rankings are by calculated gap versus a model. A premium can reflect growth expectations or data lag. Check fundamentals; seek licensed advice for personal decisions.

How often is this list updated?

The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.